Alessandro Schiavetta, MD, specialized in Cardiac Surgery in 1992 at Verona University and in Vascular Surgery in 2001 at Pavia University. He works as a vascular surgeon c/o S. Corona Hospital. Since 2009, he is the Head of the Innovative Therapies Unit c/o the Department of Vascular Surgery, S. Corona Hospital, Pietra Ligure (Savona) in Italy. His interest in stem cells therapy for peripheral arterial disease began in 2008. The NAPLES Study (Naples and Pietra Ligure Evaluation of Stem Cells), in order to set the efficacy and safety of stem cells for the treatment of peripheral arterial disease, critical limb ischemia and diabetic foot started in 2008 in collaboration with Naples University and ended in 2011. Alessandro Schiavetta, MD, specialized in Cardiac Surgery in 1992 at Verona University and in Vascular Surgery in 2001 at Pavia University. He works as a vascular surgeon c/o S. Corona Hospital. Since 2009, he is the Head of the Innovative Therapies Unit c/o the Department of Vascular Surgery, S. Corona Hospital, Pietra Ligure (Savona) in Italy. His interest in stem cells therapy for peripheral arterial disease began in 2008. The NAPLES Study (Naples and Pietra Ligure Evaluation of Stem Cells), in order to set the efficacy and safety of stem cells for the treatment of peripheral arterial disease, critical limb ischemia and diabetic foot started in 2008 in collaboration with Naples University and ended in 2011.

Surgery and Medicine